RxDoctor Payments Data

Britney Tucker

Family · Starkville, MSNPI 1972056299

Payments from drug & device makers

$1,280in general payments, 2019–2025

Across 45 payments — averaging $28.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$661
  • Novo Nordisk$125
  • AbbVie$117
  • Amgen$91
  • Vertex$90
  • Si-bone, Inc.$79
  • plus $118 from 4 others

What the payments were for

  • Food & beverage$1,280100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,280 in reported general payments places this provider in the 70th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$54,684
Medicare patients
250
Services billed
1,226

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen2,150$41,934
QuliptaAtogepant21$22,100
NucyntaTapentadol Hcl11$20,391
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen737$19,402
BelbucaBuprenorphine Hcl22$13,908
Xtampza ErOxycodone Myristate23$10,852
LinzessLinaclotide18$9,470
Ajovy AutoinjectorFremanezumab-Vfrm11$9,204
Buprenorphine28$8,271
Gabapentin817$7,797
Tizanidine Hcl353$5,569
Pregabalin320$3,802
Diclofenac Sodium128$3,599
Tramadol Hcl436$3,175
Oxycodone Hcl115$2,196

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Nucynta, Belbuca, Xtampza Er$15$45,15156 claims
AbbVieQulipta, Linzess$117$31,57039 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,007 family providers in Mississippi.

Other family in Starkville

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →